{"pageContent": "Aim: To determine whether patients undergoing transrectal ultrasound (TRUS)-guided prostate biopsy with increased sampling numbers are more likely to experience bleeding complications and whether warfarin or low-dose aspirin are independent risk factors.", "metaData": {"source": "[Treatment by HIFU of prostate cancer: survey of literature and treatment indications]\nhttps://pubmed.ncbi.nlm.nih.gov/15000326/"}}